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Available online 8 March 20085′ HoxD genes are required for the correct formation of limb skeletal elements. Hoxd13, the most 5′-located
HoxD gene, is important for patterning the most distal limb region, and its mutation causes human limb
malformation syndromes. The mechanisms underlying the control of developmental processes by Hoxd13,
and by Hox genes in general, are still elusive, due to the limited knowledge on their direct downstream target
genes. We identiﬁed by ChIP-on-chip 248 known gene loci bound in vivo by Hoxd13. Genes relevant to limb
patterning and skeletogenesis were further analysed. We found that Hoxd13 binds in vivo, in developing
limbs, the loci of Hand2, a gene crucial to limb AP axis patterning, of Meis1 and Meis2, involved in PD
patterning, of the Sfrp1, Barx1, and Fbn1 genes, involved in skeletogenesis, and of the Dach1, Bmp2, Bmp4, and
Emx2 genes. We show that Hoxd13 misexpression in developing chick limbs alters the expression of the
majority of these genes, supporting the conclusion that Hoxd13 directly regulates their transcription. Our
results indicate that 5′ Hox proteins regulate directly both key genes for early limb AP and PD axis patterning
and genes involved, at later stages, in skeletal patterning.
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Hox genes encode transcription factors belonging to the vast family
of homeodomain-containing proteins. Their main function during
development is to control cell fates and regional identities along the
primary bodyand limb axes (Favier andDolle,1997).Hox genes that are
located at the 5′ end of the HoxA and HoxD clusters (5′ Hox), display
dynamic regionally-restricted expression patterns in the developing
limbs (Nelson et al., 1996; Zakany and Duboule, 1999). The expression
of 5′ HoxD genes in limbs undergoes essentially two phases, an early
collinear phase, characterised by an overlapping posterior restriction
of their expression domains, and a late phase, in which they are
expressed with a typical AP restriction in the most distal region of the
limb (reviewed in Zakany and Duboule, 2007). These two phases
coincide with two distinct morphogenetic phases of limb formation.
The ﬁrst, is that of emerging limb buds, in which limbs are endowed
with AP polarity via the polarised expression of Hand2, Gli3 and
several 5′ Hox genes (Te Welscher et al., 2002; Zakany et al., 2004),
prior to the expression of Sonic hedgehog (Shh) within posterior meso-
derm cells of the zone of polarising activity (ZPA) (Riddle et al., 1993).
The second phase, starts with, and is dependent on Shh expression. In
this phase distal outgrowth and the speciﬁcation of the most distal
limb regions take place (Deschamps, 2004; Zakany and Duboule,. Zappavigna).
l rights reserved.2007). 5′ HoxD genes, have been shown to play a crucial role in both
phases, as they were recently found to be not solely mediators of the
Shh morphogenic signal within the limb during the second phase,
but also to be collectively required for the initiation of Shh expression
in the ﬁrst phase (Capellini et al., 2006; Kmita et al., 2005; Knezevic et
al.,1997; Tarchini et al., 2006; Zakanyet al., 2004). 5′Hox genes thus act
at several levels in the genetic pathways controlling limbdevelopment,
in relation to the different stages that this process undergoes
(Deschamps, 2004; Zakany and Duboule, 2007; Zakany et al., 2004).
Loss- and gain-of-function experiments in mouse and chick of 5′
HoxA and HoxD genes revealed that they are required for the correct
formation along both the AP and PD axes of the skeletal elements
within the three major segments (stylopod, i.e. upper arm or thigh;
zeugopod, i.e. forearm or shank; and autopod i.e. hand or foot) of the
limb, and that this is likely achieved by directing processes such as
mesenchymal cell aggregation, chondriﬁcation, and ossiﬁcation (re-
viewed in Rijli and Chambon,1997; Tickle, 2003; Zakany and Duboule,
1999). The gene regulatory networks in which they act, however, are
still largely unknown. Hox proteins are believed to regulate over-
lapping sets of target genes by binding to speciﬁc DNA sequences
within cis-regulatory elements of these, but only perhaps a subset of
the possible HOX targets have been so far identiﬁed. The use of a
variety of approaches, including microarray hybridisation screenings
and candidate gene analysis, has led to the identiﬁcation of a numberof
target genes for several vertebrate HOX proteins (Cobb and Duboule,
2005; Knosp et al., 2004; Lei et al., 2005; Morgan et al., 2003; Valerius
Table 1
Classiﬁcation of the HOXD13 target genes according to biological function
Biological process N %
Development 42 16.9
Limb 18
Gonad 10
Others 14
Cell cycle and cell proliferation 35 14.1
Cell cycle 19
Oncogenesis 8
DNA replication 6
DNA repair 3
Cell adhesion and cytoskeleton 29 11.7
Adhesion 12
Cytoskeleton 6
Cartilage 3
Others 8
Core metabolism 16 6.4
Carbohydrate 3
Lipid 3
Protein proteolysis 6
Others 4
Cell signaling 13 5.2
Small GTPase signaling 4
Others 9
Other transcription factors 13 5.2
Protein ubiquitination 11 4.4
Chromatin remodeling pathways 9 3.6
Apoptosis 8 3.2
Mitochondrial energy pathways 7 2.8
mRNA translation 4 1.6
Translation 2
Processing 2
Other known functions 18 7.2
Unknown function 43 17.3
Total 248 100.0
Gene loci corresponding to positive CpG island clones were classiﬁed according to their
Gene Ontology annotations. Each CpG island list gene (http://derlab.med.utoronto.ca/
CpGIslands.htm) was manually assigned to the indicated categories. N, total number of
genes assigned to each category. %, percentage over the total number of genes.
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the issue of a direct regulation by Hox proteins on their putative
downstream target genes, leaving the exact reconstruction of the
regulatory networks involving Hox genes a goal still to be achieved.
The development of techniques that pair chromatin crosslinking and
immunoprecipitation (ChIP) with DNA microarray technology (chip)
provides novel high-throughput tools for the identiﬁcation of
sequences directly bound in vivo by a given transcription factor
(reviewed in Wu et al., 2006).
We took advantage of the ChIP-on-chip technology to identify
direct downstream target genes for the HOXD13 protein. The Hoxd13
gene, the most 5′-located and late-activated HoxD gene, is expressed
in themost posterior parts of the embryo, the genital bud, the tail, and
the distal portion of the limbs (Dolle et al., 1991; Nelson et al., 1996).
Hoxd13 together with its paralog Hoxa13 plays a crucial role in
autopod patterning. Targeted disruption of Hoxd13 in mice causes a
considerable growth retardation of several autopodal cartilage ele-
ments and a selective loss of bony elements that develop late in wild
type animals (Davis and Capecchi, 1996; Dolle et al., 1993; Fromental-
Ramain et al., 1996). Finally, mutations in HOXD13 have been found to
cause human limb malformation syndromes, such as synpolydactyly,
characterised by speciﬁc defects in the autopod (reviewed in Good-
man, 2002).
Using a ChIP-on-chip approach, we identiﬁed 248 gene loci bound
in vivo by the Hoxd13 protein. We focused our analysis on Hoxd13-
bound genes known to play relevant roles in limb patterning, chon-
drogenesis, and skeletogenesis. We conﬁrmed the binding of Hoxd13
in vivo, in developing limbs, within the loci of Hand2, a gene crucial to
limb AP axis patterning, of the Meis1 and Meis2 genes, involved in PD
patterning, of the Sfrp1, Barx1, and Fbn1 genes, involved in skeletogen-
esis, and of theDach1, Bmp2, Bmp4, and Emx2 genes. Themisexpression
of Hoxd13 in developing chick limbs was found to perturb the
expression of Hand2, Bmp2, Bmp4, Dach1, Sfrp1, Barx1, and Fbn1,
supporting the conclusion that Hoxd13 directly regulates the tran-
scription of these genes during limb development. Our results indicate
that 5′ Hox proteins, at early stages of limb development, during their
ﬁrst, collinear phase of expression, impinge on both AP and PD axis
limb patterning by directly controlling the expression of genes that act
within key developmental pathways. At later stages, they directly
regulate the expression of genes involved in joint formation and in
determining the size of cartilage condensations, consistent with their
role in skeletal patterning.
Results
Identiﬁcation via ChIP-on-chip of gene loci bound in vivo by the HOXD13
protein
To isolate genomic sequences bound by HOXD13 in vivo via chro-
matin crosslinking and immunoprecipitation (ChIP), we generated a
cell line of mesenchymal derivation stably expressing the Flag-tagged
HOXD13 protein (Flag-HOXD13). The availability of microarrays
representing genomic sequences that correspond to transcriptional
regulatory regions required the choice of a human cell background (see
below). The human SW1353 humeral bone chondroblast cell line
(Ouyang, 1998) was thus chosen as a convenient cellular model.
SW1353 cells display mesenchymal morphology, and conserve many
of the signalling pathways of primary chondrocytes (Schaefer et al.,
2003). In addition, SW1353 cells were found to not express paralogy
group 13 and the majority of other Hox genes (VS and VZ unpublished
observation). The exogenous expression of Flag-HOXD13was achieved
by retrovirus-mediated gene transfer. SW1353 cells were transduced
with the LD13IΔN retroviral construct, or with the LXIΔN (Salsi and
Zappavigna, 2006) empty retroviral vector, and sorted to near
homogeneity. Stable and efﬁcient expression of HOXD13 in transduced
SW1353 cells was conﬁrmed both by semi-quantitative RT-PCR andwestern blot analysis (Supplementary Figs.1A andB). The effectiveness
of the Flag-HOXD13 protein was veriﬁed by testing its capability to
activate transcription from a reporter construct containing the EphA7
promoter (Salsi and Zappavigna, 2006). Flag-HOXD13 stimulated the
reporter activity with an efﬁciency comparable to that of non-tagged
HOXD13 (Supplementary Fig. 1C).
Formaldehyde-crosslinked chromatin was extracted from SW1353
cells expressing Flag-HOXD13, and immunoprecipitated with an anti-
Flag monoclonal antibody or with a control antibody. Two indepen-
dent ChIPs were performed and one set of chromatin amplicons
(average size 200–400 bp), including input DNA, control antibody, and
anti-Flag antibody was generated for each ChIP by ligation-mediated
PCR (LM-PCR). Speciﬁc enrichment in immunoprecipitations was
assessed by PCR ampliﬁcation of regulatory regions of two HOXD13
direct targets, EPHA7 (Salsi and Zappavigna, 2006) and SHH (Capellini
et al., 2006) (data not shown). Each amplicon set was used to hybridise
a microarray of 12192 human CpG island clones (Cross et al., 1994)
produced at the UHN microarray centre, Toronto, Canada (www.
microarray.ca). As CpG islands are found in the promoters and ﬁrst
exons of an estimated 70% of human genes or at other regulatory
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represents human genomic fragments highly enriched for promoter
and regulatory sequences.
Input DNA amplicons were used as an internal standard in all
hybridisations. 564 CpG island clones scored positive with an anti-
Flag/control-antibody ratio of ≥2 and were considered for further
analysis. Of these, 248 clones mapped within known loci in the UHN
CpG island database (Table 1 and Supplementary Table 1).
Table 1 shows a classiﬁcation of the identiﬁed loci according to Gene
Ontology Consortium (GO) annotations. The largest group of identiﬁed
loci (16.9%) represents genes directly involved in developmental
processes, with a prevalence of genes implicated in limb or urogenital
apparatus development. Other highly represented categories are cell
cycle/proliferation (14,1%), and cell adhesion (11.7%). Given the relevant
role played byHoxd13 in limb patterning, skeletogenesis, and urogenital
development (Davis and Capecchi, 1996; Dolle et al., 1993; Fromental-
Ramain et al., 1996; Goodman, 2002), we selected 40 loci for further
analysis, based on their established role in these processes, in
developmental processes in general, and/or on their positive score in
all hybridisations. A ﬁrst validation was performed using chromatin
from SW1353 cells expressing HOXD13. Three independent ChIPs were
performed, and the enrichment for HOXD13 binding regions was
veriﬁed by semiquantitative PCR analysis. PCR primers were designed
to span genomic regions within and/or adjacent to the hybridising CpG
island clones (Supplementary Table 2). Genomic regions of 26 loci
were consistently enriched in the anti-Flag antibody samples (Fig. 1A),
conﬁrming binding in vivo of HOXD13 to these sequences. Conversely,
the genomic regions within EVC, TLL1, TBX15, LEMD3, DMRT1/DMRT3,
SPAG4, FSHPRH1, ESX1L, RHBDL2, SOX14, ITGB8, ADAM19, ADAM2, and
HOXA7 genes were not signiﬁcantly enriched (data not shown).
In addition,we analysed by ChIP the binding of HOXD13 to genomic
sequences within three different candidate direct target loci, SFRP1,
BMP2, and BMP4 (Fig. 1A). SFRP1 is involved in limb development
(Satoh et al., 2006), and its expressionwas signiﬁcantly up-regulated in
a gene expression proﬁling analysis of HOXD13-expressing SW1353
cells (VS and VZ unpublished observation). BMP2 was shown to be a
direct target of the paralogous Hoxa13 protein (Knosp et al., 2004),
while the BMP4 promoter was shown to be bound in vitro by Hoxd13
and Hoxa13 (Suzuki et al., 2003). ChIP experiments on SW1353 cells
expressing HOXD13 showed a signiﬁcant enrichment of the tested
SFRP1, BMP2, and BMP4 genomic regions, indicating that they are
bound in vivo by HOXD13 as well (Fig. 1A).
As a control, the loci bound in vivo by HOXD13 were also tested by
ChIP for binding by the HOXB1 protein. SW1353 cells were transiently
transfected with an expression construct for HOXB1 to obtain high-
level expression (Supplementary Fig. 2A). ChIP analysis showed that
none of the loci bound by HOXD13 were bound by HOXB1 in vivo in
SW1353 cells (Supplementary Fig. 2B). This result indicates that other
non-AbdB related Hox proteins do not bind non-speciﬁcally to the loci
bound in vivo by HOXD13 in the same experimental conditions.
Hoxd13 binds in vivo during limb development to genes involved in
crucial limb patterning pathways
We further focused our analysis on 11 genes that are relevant to
limb patterning and/or cartilage/bone formation, and veriﬁed binding
of Hoxd13 to their genomic sequences in vivo during limb develop-
ment. The Sfrp1, Bmp2 and Bmp4 genes were also included in this
analysis. Chromatin was prepared from mouse whole E11.5 fore- and
hind-limb buds, and from E13.5 distal fore- and hind-limbs. A speciﬁc
anti-Hoxd13 antibody (Imgenex, San Diego, USA) was used in ChIP
experiments. The speciﬁcity of the antibody was veriﬁed in immuno-
precipitation experiments (Supplementary Fig. 3). Out of the 14 tested
loci (including Sfrp1, Bmp2 and Bmp4), 13 showed a signiﬁcant en-
richment in immunoprecipitated limb chromatin of the same se-
quences bound by HOXD13 in SW1353 cells, conﬁrming the binding invivo of Hoxd13 to these loci also during limb development (Fig. 1B).
Regions from the Hand2, Dach1, Barx1, Fbn1, Sfrp1, and Bmp4 genes
were bound by Hoxd13 both at E11.5 and E13.5. Sequences from the
Meis1, Meis2, Emx2, Bmp2, and Il4r loci were bound only at E11.5, and
from Pp2ca and Del1 only at E13.5 (Fig. 1B). As a control, ChIP expe-
riments were performed using chromatin extracted from E13.5 mouse
brain, a tissue that does not express Hoxd13 (Dolle et al., 1991). No
enrichment of the tested regions was observed (Fig. 1C). As a further
control, we veriﬁed the enrichment of regions located at a distance of
500–2000 bp from the Hoxd13-bound sequences. No enrichment was
observed for all control regions (Fig. 1D). Primers used for PCR analysis
are listed in Supplementary Table 2. These results show that the majo-
rity of the tested genes, bound by exogenously-expressed HOXD13 in
SW1353 cells, are also bound by endogenous Hoxd13 in vivo during
mouse limb development, conﬁrming the effectiveness of the SW1353
cellular model. Hoxd13 binds within the loci of genes involved in
crucial processes during limb development, such as limb AP axis
patterning (Hand2), PD patterning (Meis1 and Meis2), chondrogenic
condensation initiation/interdigital cell death (Bmp2 and Bmp4), and
skeletogenesis (Sfrp1, Barx1, and Fbn1).
Regulation of Hoxd13-bound genes expression by Hoxd13 during limb
development
We next wanted to verify whether the expression during limb
development of the gene loci bound by Hoxd13 in vivo could indeed be
perturbed by changes in Hoxd13 expression levels. To this end, we
chose a gain-of-function/misexpression approach, as in a Hoxd13 loss-
of-function model, changes in target gene expression are likely to go
undetected, due to the high degree of functional redundancy observed
for paralogy group 13, and, more in general, for 5′ HoxA and HoxD
genes in the limb (Davis and Capecchi, 1996; Favier et al., 1996; Fro-
mental-Ramain et al., 1996; Zakany and Duboule, 1996). We antici-
pated that in gain-of-function experiments, higher levels of orthotopic
and/or ectopicHOXD13 expressionwould cause a detectable perturba-
tion of the target genes expression.
To misexpress HOXD13 we used a recombinant replication-com-
petent avian retroviral construct (RCAS-HOXD13) (Caronia et al., 2003).
An RCAS-HOXD13 retroviral suspension was injected in ovo into the
prospective right hindlimb ﬁeld of stage 10 chick embryos to obtain a
uniform infection of mesenchymal cells (Morgan and Fekete, 1996).
The left uninjected limbs served as internal controls. A retroviral
construct expressing alkaline phosphatase (Morgan and Fekete,1996),
used in control experiments, conﬁrmed that the entire right leg bud
was infected at high frequency (data not shown). The expression
patterns of the identiﬁed targets geneswere analyzed bywhole-mount
in situ hybridisation.
Hoxd13 misexpression up-regulates Hand2 transcription in developing
chick limbs
Hand2 encodes a basic helix–loop–helix (bHLH) transcription
factor, required for the establishment of an AP prepattern and for
Shh signalling in limbs (Fernandez-Teran et al., 2000; Srivastava et al.,
1997). Hand2 is expressed initially throughout the ﬂank mesenchyme
and subsequently in the posterior limb bud mesenchyme. At later
stages, Hand2 is also expressed in the autopod, essentially in the
interdigital space, concentrating eventually at the lateral borders of the
developing digits (Fernandez-Teran et al., 2000).
In chick limbs misexpressing HOXD13, at HH stages 20 and 23,
Hand2was found to bemarkedly up-regulated in its normal expression
domain, and in addition displayed a striking ectopic distal anterior
domain of expression (Fig. 2A). Later stages (HH 30 and 32), still
showed a signiﬁcant up-regulation of Hand2 expression especially
in the autopod, in the interdigital spaces at HH stage 30, and at
the lateral borders of the digits at HH stage 32 (Fig. 2A). The up-
Fig. 1. Validation of candidate HOXD13 direct target genes. (A) Forty positively-scoring loci were validated by ChIPs of FlagHOXD13-expressing SW1353 cells (SW-HOXD13). (D13), α-
Flag antibody; (CA), α-MycTAG control antibody; (I), input chromatin. Enrichment of HOXD13-binding regions was validated by semiquantitative PCR (primers in Supplementary
Table 2). Left panel, shows loci displaying consistent and signiﬁcant enrichment. Right panel, validation by ChIP of the candidate direct targets SFRP1, BMP2, and BMP4. (B) In vivo
binding of endogenous Hoxd13 to candidate targets in developing limbs at E11.5 (left) or E13.5 (right). (C) Control ChIP analysis on E11.5 brain chromatin. (D) For each target locus, a
non-conserved genomic region ∼500–2000 bp upstream to the CpG island was PCR ampliﬁed as control. (D13), α-Hoxd13 antibody; (CA), α-FLAG control antibody; (I), input
chromatin. All ChIPs and semiquantitative PCRs were performed in triplicate; representative experiments are shown.
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in 12 out of 12 (100%) embryos analysed. Interestingly, despite a slight
but recognisable alteration of the limb bud morphology at stages 20
and 23 (Fig. 2A), the anterior ectopic expression of Hand2 was not
accompanied by any overt changes in distal limb morphology at later
stages (Fig. 2A). This is in accordance with the reported phenotype of
Hoxd13-misexpressing limbs (Caronia et al., 2003; Goff and Tabin,
1997).
An evolutionarily conserved regulatory element within the Hand2 locus
mediates transcriptional activation by Hoxd13
We then tested the Hand2 genomic region bound by Hoxd13 in
vivo for its capability to mediate transcriptional regulation by
Hoxd13. Hoxd13 binds to an evolutionarily conserved region 3′ to
the last exon of Hand2 (Fig. 2B, top). A ∼980 bp fragment, spanning
the CpG island clone sequence, and containing the region tested by
ChIP (Fig. 2B, top), was cloned into the pT81luc reporter (pT81Hand2,
Fig. 2B, bottom). P19 embryonal carcinoma cells were transiently
transfected with the pT81Hand2 reporter together with increasing
amounts of the pSGHOXD13 expression construct. In accordance with
the up-regulation of Hand2 observed in chick limbs misexpressing
Hoxd13 (Fig. 2A), HOXD13 signiﬁcantly increased the basal reporter
activity (Fig. 2B, bottom). An interspecies comparison of the tested
genomic region (Supplementary Fig. 4A), revealed the presence of
evolutionarily-conserved sequences having the core motifs TTAT or
TTAC that are characteristic of the optimal DNA-binding sequence of
paralog group 13 Hox proteins (Caronia et al., 2003; Salsi and
Zappavigna, 2006), and therefore represent potential binding sites
for Hoxd13.
Taken together, these data indicate that Hoxd13 directly controls
the expression of Hand2 in developing limbs via an evolutionarily
conserved cis-regulatory element located 3′ to its last exon.Dach1 expression is up-regulated by Hoxd13 misexpression
Dach1, together with its cognate Dach2, are orthologues of the
Drosophila dachshund (dac) gene, which is required for correct
proximo-distal leg patterning (Mardon et al., 1994). In developing
chick limbs,Dach1 is expressed, at stages 19–20, in the AER, and in two
major mesenchymal domains, at the anterior and posterior margins of
the bud, respectively. At later stages (23–25), Dach1 transcript con-
centrateswithin these two domains, whilemoremedial–distal regions
show only low-level expression (Heanue et al., 2002; Kida et al., 2004
and Fig. 3A).
At stage 20, in limbs misexpressing HOXD13, Dach1 was signiﬁ-
cantly up-regulated in its anterior and posterior mesenchymal expres-
sion domains, as well as in medial–proximal bud regions (Fig. 3A). At
later stages (22 and 24), Dach1 was still up-regulated at the anterior
and posterior margins, and to a lesser extent in the central portion, of
the bud mesenchyme (Fig. 3A). Dach1 expression within the AER was
also up-regulated at stage 22 (data not shown). The up-regulation of
Dach1 expression was observed in 20 out of 21 (95%) embryos
analysed.
Hoxd13 activates transcription via a conserved regulatory element
within the ﬁrst intron of the Dach1 gene
We then tested whether the Dach1 genomic region bound by
Hoxd13 in vivo could mediate transcriptional regulation by Hoxd13.
Hoxd13 bindswithin theDach1 locus to a short evolutionarily conserved
region located in the ﬁrst intron (Fig. 3B, top). A fragment of ∼760 bp,
spanning the CpG island clone sequence and the region tested by ChIP,
was used to generate the pT81Dach1 reporter. pT81Dach1 was trans-
fected in P19 cells together with increasing amounts of pSGHOXD13.
Consistently with Dach1 up-regulation in developing limbs, HOXD13
activated the basal activity of the pT81Dach1 reporter (Fig. 3B, bottom).
Fig. 2. Hoxd13 up-regulates Hand2 expression. (A) Whole-mount in situ hybridisations on chick limbs misexpressing Hoxd13 (RCAS-Hoxd13), and on control uninjected left limbs of
the same embryos (Contr.). Approximate embryonic stages (Hamburger and Hamilton, 1992) are indicated. White arrowheads indicate ectopic Hand2 expression. (B) HOXD13
activates transcription from the Hand2 genomic fragment. Upper panel shows an interspecies comparison of the HOXD13-bound murine region using the USCS Genome Browser
(Kent et al., 2002). Black box, genomic fragment tested in transfections. White box, sequence of the CpG island clones. Striped box indicates the fragment that was PCR ampliﬁed to
validate Hoxd13 binding by ChIP. Lower panel shows the luciferase activity of P19 cells, transfectedwith pT81-Hand2 together with increasing amounts of the pSGHOXD13 expression
vector. Error bars represent the mean luciferase activity±S.E. of at least four independent experiments.
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this case the presence of an evolutionarily-conserved sequence having
the characteristic TTAT core motif, thus representing a potential Hoxd13
binding site (Supplementary Fig. 4B).
Bmp2 and Bmp4 expression is up-regulated by Hoxd13 misexpression
Bmp2 and Bmp4 are both expressed in the proximal limb mesen-
chyme and in the AER. At early stages Bmp2 expression is conﬁned to
the posterior AER and mesoderm, while Bmp4 displays an additional
domain of strong mesenchymal expression anteriorly and proximally
(Geetha-Loganathan et al., 2006) and Figs. 4A and B). In limbs mis-
expressing Hoxd13 Bmp2 expression was up-regulated within its
posterior mesodermal domain, which was slightly expanded distally
(Fig. 4A). Within the AER, which appeared to extend more anteriorly
than in uninjected limbs, Bmp2 expressionwas both up-regulated and
expanded anteriorly (Fig. 4A). The described perturbations in Bmp2
expression were observed in 12 out of 14 (85%) embryos analysed.
Similarly, Bmp4 expression was up-regulated within the mesenchyme
especially at the anterior, both at stage 20 and at stage 24 (Fig. 4B).
Bmp4 was also found to be signiﬁcantly up-regulated within the AER,
and its expressionwas expanded anteriorly (Fig. 4B). At stage 30, Bmp4
expression was still up-regulated in the interdigital tissue (Fig. 4B).
Alterations in Bmp4 expression were observed in 8 out of 10 (80%)
embryos analysed. Thus, both Bmp2 and Bmp4 are up-regulated
following the misexpression of Hoxd13. Interestingly, while the
AER displayed an ectopic anterior expansion of Bmp2 and Bmp4
expression, no high-level ectopic expression was observed in the bud
mesenchyme.
Finally, we also tested in limbs misexpressing HOXD13 for possible
perturbations in the expression of Emx2, a gene involved in limb girdle
formation. No signiﬁcant changes in Emx2 expression were observed
in injected limbs at stages 20 to 30 (data not shown).Hoxd13 misexpression perturbs the expression of the Barx1, Sfrp1, and
Fbn1 genes
Barx1 encodes a homeodomain protein, expressed in the develop-
ing joints and articular cartilage of the limb. At stage 24, it is expressed
proximally, likely marking the developing elbow/knee regions. From
stage 28 onwards, additional expression domains appear, correspond-
ing to the wrist/ankle regions and to the digit condensations. Barx1 is
associatedwith the chondrocytes thatwill form the skeletal epiphyseal
regions (Barlow et al., 1999 and Fig. 5A). Barx1 expression in chick
limbs misexpressing Hoxd13 was consistently down-regulated. At
stages 28, 30, and 32, the down regulationwas observedmainlywithin
the autopod, in the articular cartilage of the digits, and to a lesser
extent within the knee region at the posterior end of its proximal
expression domain (Fig. 5A). The down-regulation of Barx1 expression
was observed in 9 out of 10 (90%) embryos analysed.
The Barx1 genomic region bound by Hoxd13 in vivo was tested for
transcriptional regulation by Hoxd13. Hoxd13 binds within the Barx1
locus to a short evolutionarily conserved region located at the 3′ of the
gene (Fig. 5C, top). A fragment of ∼510 bp, spanning the region tested
by ChIP, was used to generate the pT81Barx1 reporter. pT81Barx1was
transfected in P19 cells together with increasing amounts of
pSGHOXD13. In accordance with the Barx1 down-regulation in deve-
loping limbs, HOXD13 repressed the pT81Barx1 reporter basal activity
(Fig. 5C, bottom). An interspecies comparison of the tested genomic
region is shown in Supplementary Fig. 4D. It reveals the presence of a
single potential evolutionarily conserved Hoxd13 binding site having
the characteristic TTAT core motif.
Sfrp1 encodes a secreted Wnt signalling antagonist (reviewed in
Kawano and Kypta, 2003). Sfrp1 is expressed, during early limb
development, in a proximal anterior domain in the zeugopod and in
two distinct distal regions, anterior and posterior, within the mesen-
chyme underlying the AER (Fig. 5B). At later stages Sfrp1 expression
Fig. 3.Hoxd13 activates the expression of Dach1. (A) Whole-mount in situ hybridisations on chick limbs misexpressing Hoxd13 (RCAS-Hoxd13), and on control uninjected left limbs of
the same embryos (Contr.). Approximate embryonic stages (Hamburger and Hamilton, 1992) are indicated. White arrowheads indicate perturbed Dach1 expression. (B) HOXD13
activates transcription from the Dach1 genomic sequence. Upper panel shows an interspecies comparison of the HOXD13-bound murine region as in Fig. 2. Black box, genomic
fragment tested in transfections. White box, sequence of the CpG island clone. Striped boxes indicate fragments that were PCR ampliﬁed to validate Hoxd13 binding by ChIP. Lower
panel shows the luciferase activity of P19 cells, transfected with pT81-Dach1 together with increasing amounts of the pSGHOXD13 expression vector. Error bars represent the mean
luciferase activity±S.E. of at least four independent experiments.
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mulate in the regions surrounding the joints and between the digits
(Terry et al., 2000 and Fig. 5B).
Upon misexpression of Hoxd13, Sfrp1 expressionwas up-regulated,
at stage 25, both in its proximal–anterior domain, as well as in the
distal autopodal region (Fig. 5B). At stage 30, Sfrp1 was still up-
regulated both in the zeugopod, and within the autopod at the lateral
borders of the digits, with a more marked increase at the anterior
border of digits two and three (Fig. 5B). The up-regulation of Sfrp1
expression was observed in 8 out of 8 (100%) embryos analysed.
Fibrillin-1 (Fbn-1) is a major component of extracellular micro-
ﬁbrils (Sakai et al., 1986). In the autopod, Fbn1 displays, at stage 25, a
more intense expression in the anterior–distal mesechyme, with a
more proximally expanded domain in the prospective digit three
region (Fig. 6A). At stage 32, Fbn-1 is expressed at the lateral borders of
the forming digits, and more intensely in the regions of the forming
joints (Fig. 6A). In chick limbs misexpressing Hoxd13, Fbn-1 was up-
regulated, at stage 25, mainly within the medio-distal region,
corresponding to the prospective digit three region (Fig. 6A). At stage
32, Fbn-1 up-regulation was detectable in all digits, and in particular,
anteriorly, at the lateral borders andwithin the joint region of digit two
(Fig. 6A). The up-regulation of Fbn-1 expressionwas observed in 12 out
of 15 (80%) embryos analysed.
A conserved region within the Fbn1 promoter mediates transcriptional
activation by Hoxd13
Hoxd13 binds to the proximal promoter region of Fbn1 (Fig. 6B,
top). To test whether this region was capable of mediating transcrip-
tional activation by Hoxd13, a ∼1500 bp fragment, spanning the Fbn1
putative transcription start site and comprising both the CpG island
clone sequence and the region tested by ChIP, was cloned into the
pXP2 promoterless reporter (pXPFbn1, Fig. 6B, bottom). pXPFbn1 wasco-transfected with increasing amounts of pSGHOXD13 in P19 cells.
HOXD13 expression led to a marked increase of the reporter activity
(Fig. 6B, bottom), in agreement with the up-regulation of Fbn1 ob-
served in chick limbs (Fig. 6A). An interspecies alignment of the Fbn1
promoter sequence revealed the presence of a possible Hoxd13
binding site having the core motif TTAC (Supplementary Fig. 4C).
Discussion
The molecular basis of morphogenetic processes, in particular of
those controlled by Hox genes, is still largely obscure. This is mainly
due to the limited knowledge on the target genes controlled by Hox
proteins, and thus on the regulatory networks in which these act. We
approached the identiﬁcation of direct downstream targets for Hoxd13
by using the ChIP-on-chip technique (Wu et al., 2006) on a microarray
of 12192 human CpG island clones (Cross et al., 1994). Despite the fact
that not all Hoxd13 binding sites can be expected to lie in the proximity
of a CpG island and that theDNA sequence of only about 79% of the CpG
island clones of the microarray was found to align with known geno-
mic regions (Heisler et al., 2005), we anticipated that our screening,
while not exhaustive, would nevertheless lead to the identiﬁcation of a
number of candidate direct target genes that participate in the
biological processes controlled by Hoxd13. Indeed, we could identify
248 known loci bound in vivo by the Hoxd13 protein in cells of mesen-
chymal derivation. Given the central role played by 5′ Hoxd genes and
by Hoxd13 in limb development (Goodman, 2002; Rijli and Chambon,
1997; Tickle, 2003), we chose to focus our subsequent analysis on a set
of Hoxd13-bound genes that play important roles in limb develop-
ment/skeletogenesis. Nearly all of the loci representing genes involved
in limb patterning and/or in cartilage/bone formation bound by
Hoxd13 in SW1353 cells were also found to bind endogenous Hoxd13
in vivo during limb development, substantiating the validity of this
cellular model. Our results show that Hoxd13 binds within the loci of
Fig. 4. Hoxd13 activates the expression of Bmp2, and Bmp4 in chick limbs. Whole-
mount in situ hybridisations on chick limbs misexpressing Hoxd13 (RCAS-Hoxd13), and
on control uninjected left limbs of the same embryos (Contr.). Approximate embryonic
stages (Hamburger and Hamilton, 1992) are indicated. (A) Bmp2 expression. (B) Bmp4
expression. White arrowheads indicate anterior ectopic expression of Bmp2 or Bmp4
within the AER, and sites of up-regulation.
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such as limb AP axis patterning (Hand2), PD patterning (Meis1 and
Meis2), chondrogenic condensation initiation/interdigital cell death
(Bmp2, Bmp4), and skeletogenesis (Sfrp1, Barx1, and Fbn1). The
misexpression of Hoxd13 in developing chick limbs showed that the
expression of themajority of these geneswas perturbed by an increase
in Hoxd13 expression levels, supporting the conclusion that Hoxd13
directly regulates their expression.
Hoxd13, 5′ Hox genes, and the regulatory networks controlling limb
patterning
Functional redundancy and additive actions between 5′ HoxD
genes in limb development arewell documented (Davis and Capecchi,1996; Kmita et al., 2005; Tarchini et al., 2006; Zakany et al., 2004). The
isolation of target genes that are controlled solely by a single Hox
protein can be therefore considered as unlikely. We actually expect
that the expression of a large subset of the genes bound in vivo by
Hoxd13 we identiﬁed is not exclusively controlled by Hoxd13, but is
likely to be regulated byother 5′HoxAorHoxDproteins aswell. Recent
evidence indeed suggests that downstream targets that are controlled
by 5′Hox genes during their ﬁrst, collinear phase of expression require
the concomitant activation bymultiple Hox proteins to be transcribed.
The loss of Shh expression, for example, requires the simultaneous
deletion of at least four 5′Hoxd genes in the context of a completeHoxa
deletion (Tarchini et al., 2006), while the mutation of single 5′ Hox
genes typically does not affect the overall AP polarity of the limb, hence
the expression of Shh (Rijli and Chambon, 1997; Zakany and Duboule,
1999).
We anticipate as well that the expression of the majority, if not of
all, of the Hoxd13-bound genes we identiﬁed, is not exclusively
controlled by Hox proteins. Indeed, the expression patterns within the
limb of these genes only partially overlap the expression pattern of
Hoxd13 or of other 5′ Hox genes. The misexpression of Hoxd13
throughout the whole limb mesenchyme, moreover, did not lead to a
non-speciﬁc widespread expression of the tested Hoxd13-bound
genes. A localised ectopic expression was observed only in the case of
Hand2, whereas Dach1, Bmp2, Bmp4, Sfrp1, and Fbn1 displayed
essentially an increase in expression levels within their normal
expression domains. This suggests that Hoxd13 controls the expres-
sion of these genes only in regulatory contexts that are permissive for
their transcription, and that their expression is likely not initiated by
Hoxd13 or by other 5′ Hox genes. The transcriptional control by
Hoxd13 on these genes would thus be integrated at cis-regulatory
modules, located within their promoters, with the regulation by other
transcription factors acting in speciﬁc regulatory pathways. Further
work will be required to fully characterise the cis-regulatory elements
mediating Hox function within the identiﬁed target genes, and to
understand how their activity is integrated with that of other
regulatory modules.
Hoxd13 regulates the expression of Hand2, a key gene in limb AP axis
patterning
Reciprocal antagonism between the basic helix–loop–helix (bHLH)
transcription factor Hand2 and the Gli3 repressor is important for limb
bud AP axis patterning prior to Shh expression (Te Welscher et al.,
2002) (Fig. 7). Hand2 was shown to be both necessary and sufﬁcient
for initiating Shh expression in developing limbs (Charite et al., 2000;
Fernandez-Teran et al., 2000; McFadden et al., 2002; Srivastava et al.,
1997). Recently, 5′ HoxA and HoxD (5′ Hox) genes have been also
shown to play a key role in initiating Shh expression (Capellini et al.,
2006; Kmita et al., 2005; Tarchini et al., 2006; Zakany et al., 2004).
Hand2 expression, which starts before Shh expression, is restricted
to the posterior mesenchyme of the limb buds in a domain that
encompasses the Shh expression domain, and that of several 5′ HoxD
and HoxA genes, including Hoxd13, during their ﬁrst, collinear, phase
of expression (Fernandez-Teran et al., 2000; Nelson et al., 1996). Our
results showing the binding in vivo of Hoxd13 during limb develop-
ment to an evolutionarily conserved region within the Hand2 locus,
and the perturbation of Hand2 expression following misexpression of
Hoxd13, indicate that Hoxd13, is a direct upstream regulator of Hand2
expression in the posterior limb bud. According to these results,
Hoxd13, likely in concert with other co-expressed 5′ Hox genes, via the
activation of Hand2 would play an active role in the establishment,
prior to Shh expression, of an AP axis prepattern (Te Welscher et al.,
2002) within the limb bud (Fig. 7). Subsequently, Shh signalling would
be sustained by 5′ HoxD genes by a dual mechanism: via the direct
activation of Shh (Capellini et al., 2006) and via the activation of its
upstream regulator Hand2 (Fig. 7).
Fig. 5. Hoxd13 represses Barx1, and up-regulates Sfrp1 expression. Whole-mount in situ hybridisations on chick limbs misexpressing Hoxd13 (RCAS-Hoxd13), and on control
uninjected left limbs of the same embryos (Contr.). Approximate embryonic stages (Hamburger and Hamilton, 1992) are indicated. (A) Barx1 expression is repressed. Arrowheads
highlight down-regulated domains of Barx1 expression. (B) Sfrp1 expression is up-regulated. White arrowheads indicate sites of perturbed Sfrp1 expression. (C) HOXD13 represses
transcription from the Barx1 genomic sequence. Upper panel shows an interspecies comparison of the HOXD13-bound murine region as in Fig. 2. Black box, genomic fragment
tested in transfections. White box, sequence of the microarray clone. Striped boxes indicate fragments that were PCR ampliﬁed to validate Hoxd13 binding by ChIP. Lower panel
shows the luciferase activity of P19 cells, transfected with pT81-Barx1 together with increasing amounts of the pSGHOXD13 expression vector. Error bars represent the mean
luciferase activity±S.E. of at least three independent experiments.
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The correct development of the limb proximal–distal (PD) axis
requires the early bud to be divided in a proximalMeis-expressing and
a distal Meis-negative domain (Mercader et al., 1999, 2000). Distal
ectopic expression ofMeis1 orMeis2 causes the deletion of distal limb
structures and a proximalisation of regional identities (Capdevila et al.,
1999; Mercader et al., 1999). Hoxd13 has been previously reported to
down-regulate the expression of Meis genes (Capdevila et al., 1999).
We found that both Meis1 and Meis2 are bound by Hoxd13 in vivo in
E11.5 mouse limb buds, indicating that their expression is directly
controlled by 5′ Hox proteins. We also show that Hoxd13 binds to in
vivo and up-regulates the expression in chick limbs of another gene
that could be potentially involved in PD limb patterning, Dach1. Dach1
andDach2, are orthologues of theD. dachshund (dac) gene and are both
expressed in developing limbs (Heanue et al., 2002; Kida et al., 2004).
In the limbs, Dach1 is expressed in a pattern that overlaps posteriorly
that of Hoxd13 (Heanue et al., 2002; Kida et al., 2004; Nelson et al.,
1996). dachshund encodes a nuclear DNA-binding protein crucial for
PD patterning of the ﬂy’s appendages, as its loss-of-function results in
the deletion of the intermediate leg segments (Mardon et al., 1994).
Targeted inactivation in mice, of Dach1 or of Dach2, or of both genes,
however, did not cause overt alterations of limb development (Davis
et al., 2001, 2006). Dach1 has nevertheless been proposed to
participate in limb PD axis patterning and AER maintenance via the
intracellular modulation of BMP signalling (Kida et al., 2004;Wu et al.,
2003). Misexpression of a VP16–Dach1 fusion, which behaves as a
transcriptional activator that abrogates Dach1-mediated repression, in
developing chick limbs caused severe truncations in the distal
autopod, mimicking the misexpression of a constitutively active
BMP receptor. Andmisexpression of the DD2 dominant-negative formof Dach1 induced expansion of proximalMeis2 expression (Kida et al.,
2004), suggesting that Dach1 might repress the expression of Meis
genes, in analogy to the repression of D. dachshund on the more
proximally expressed homothorax gene (the ortholog of Meis genes)
(Abu-Shaar and Mann, 1998). Thus, our results suggest that Hoxd13,
and thus possibly other 5′ Hox genes, promote distal limb develop-
ment, both by directly antagonizing the action of Meis genes, and by
activating the expression of Dach genes in more distal limb regions
(Fig. 7).
Hoxd13 and Bmp gene expression
Bone morphogenetic proteins (BMPs), and in particular BMP2,
BMP4, and BMP7, have been implicated in various aspects of limb
development (see Bandyopadhyay et al., 2006). Recently the role of
these BMPs in some limb morphogenetic processes has been chal-
lenged. Loss of BMP2 and BMP4 has been shown to cause mainly the
absence of posterior digits, due likely to a block in mesenchymal cell
condensation and the consequent failure to initiate chondrogenesis,
and, at later stages, an arrest in osteogenesis and the lack of interdigital
apoptosis, inducing the appearance of webbing between the digits
(Bandyopadhyay et al., 2006).
Bmp2 has been shown to be a direct target of the Hoxa13 protein
(Knosp et al., 2004), and the Bmp4 promoter has been reported to be
bound in vitro by Hoxa13 and Hoxd13 (Suzuki et al., 2003), suggesting
that their expression might be directly controlled by Hoxd13 during
distal limb development. The expression domain of Hoxd13 overlaps
that of Bmp2 and Bmp4 both at early stages of limb development
within the posterior mesoderm, as well as at later stages in the
interdigital tissue. Our results indicate that Bmp2 and Bmp4 expres-
sion is directly regulated by Hoxd13, implicating Hoxd13, and thus
Fig. 6. Hoxd13 up-regulates Fbn1 expression. (A)Whole-mount in situ hybridisations on
chick limbs misexpressing Hoxd13 (RCAS-Hoxd13), and on control uninjected left limbs
of the same embryos (Contr.). Approximate embryonic stages (Hamburger and
Hamilton, 1992) are indicated. White arrowheads indicate sites of perturbed Fbn1
expression. (B) HOXD13 activates transcription from the Fbn1 promoter. Upper panel
shows an interspecies comparison of the HOXD13-bound murine region. Black box,
genomic fragment tested in transfections. White box, sequence of the CpG island clone.
Striped box indicates the fragment thatwas PCR ampliﬁed to validate Hoxd13 binding by
ChIP. Lower panel shows the luciferase activity of P19 cells, transfected with pXP-Fbn1
together with increasing amounts of the pSGHOXD13 expression vector. Error bars
represent the mean luciferase activity±S.E. of at least four independent experiments.
Fig. 7. Hoxd13 directly controls genes that act at different levels within developmental
pathways controlling patterning at early stages of limb development. The possible
control by other 5′ HoxA or HoxD proteins is indicated (5′ Hox). Genes and their
corresponding expression patterns within the limb bud are indicated with the same
colour. Lines ending with arrows or bars represent activation or repression, respectively.
Regulatory interactions characterised in this work are highlighted in red.
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(Fig. 7) and in the control of interdigital cell death.
Hoxd13 and distal limb skeletogenesis
Distal limb skeletal elements arise from a prepattern of condensed
mesenchyme blocks that is formed as a result of the progressive
branching and segmentation of chondrogenic condensations. Hox
genes are considered to play a fundamental role in these processes
(reviewed in Rijli and Chambon, 1997; Zakany and Duboule, 1999). We
found that Hoxd13 binds in vivo and regulates the expression of the
Sfrp1, Barx1, and Fbn1 genes, implicated in cartilage cell differentiation
and maturation, and in joint formation.
Sfrp1 encodes a secreted polypeptide that antagonizes canonical
Wnt/β-catenin signalling (Kawano and Kypta, 2003). The Sfrp1 trans-
cript is found in the mesenchymal cells surrounding the forming digitcartilage, and at later stages it accumulates in the regions adjacent to
the joints and between the digits (Terry et al., 2000). Sfrp1 and its
cognate Sfrp2 have been shown to havemostly overlapping expression
patterns and to be largely functionally redundant in mouse embry-
ogenesis. Sfrp1 and Sfrp2 double mutant mice display pre-axial extra
digits and limb outgrowth defects that are reminiscent of the deﬁ-
ciencies observed in mice and chicken overexpressing Wnts or cons-
titutively active β-catenin, strongly suggesting that Sfrp1 and Sfrp2
indeed participate in regulating Wnt signalling during skeletogenesis
(Satoh et al., 2006). Canonical Wnt signalling has been recently shown
to be important for joint development and hence for controlling the
size of limb skeletal elements (Guo et al., 2004; Spater et al., 2006 and
references therein). Thus Hoxd13, by directly regulating Sfrp1 expres-
sion, would regulate canonical Wnt signalling during the formation of
autopodal skeletal elements.
Barx1 encodes a homeodomain protein of the Bar subclass, and is
related to the Drosophila BarH1 and BarH2 genes, which were shown
to be required for the formation and speciﬁcation of distal limb seg-
ments in the ﬂy (Kojima et al., 2000). In developing vertebrate limbs,
Barx1 is expressed in discrete regions that correspond to zones of
prospective articular cartilage formation (Barlow et al., 1999). Within
the autopod, the expression of Hoxd13 appears to be complementary
to that of Barx1, as it marks the mesenchymal cell layer adjacent to the
perichondrium of the digit condensations (Suzuki and Kuroiwa, 2002),
suggesting that these genes might play opposing roles in the
differentiation/maturation of chondrocytes within the condensations.
Indeed, we found that Hoxd13 misexpression signiﬁcantly down-
regulates the expression of Barx1 especially in the digits. Barx1 was
furthermore shown to be required for Sfrp1 expression in gastric
mesenchymal cells, suggesting that it is implicated in the regulation of
Wnt signalling as well (Kim et al., 2005). The role of Barx1 in limb
skeletal element formation is, however, still unclear, as Barx1 null
mutant mice have been characterised only regarding their gastric
phenotype (Kim et al., 2005). Further work will be required to
506 V. Salsi et al. / Developmental Biology 317 (2008) 497–507understand the role of Barx1 in chondrogenesis and sinovial joint
formation.
Fbn1 codes for an extracellularmatrix glycoprotein,which, together
with the cognate Fbn2, is a major component of extracellular micro-
ﬁbrils (reviewed in Robinson et al., 2006). Mutations in the Fbn1 gene
have been shown to cause Marfan syndrome (MFS), an autosomal
dominant disorder of the connective tissue affecting mainly the
skeletal, ocular, and cardiovascular systems. Patients withMFS display
characteristic limb abnormalities including disproportionately long
limbs (dolichostenomelia) and digits (arachnodactyly) (Robinson et al.,
2006). The insoluble extracellular matrix likely exerts more than a
merely structural role in the developing mesenchyme by providing a
framework that can speciﬁcally arrange morphogenetic cues in the
intercellular space. Indeed, the targeted inactivation of the Fbn2 gene,
which causes syndactyly involving the ﬁrst phalanges of digits 2 to 4,
has been shown to affect Bmp signalling in the interdigital regions of
the developing limbs (Arteaga-Solis et al., 2001). Hoxd13 may there-
fore control the formation and size of cartilaginous structures in the
autopod by controlling also extracellular matrix organization and
composition. The mechanisms regulating Fbn1 expression during
development are still largely unknown. To our knowledge Hoxd13
represents the ﬁrst transcription factor reported to regulate Fbn1
expression during embryogenesis.
Materials and methods
Plasmid constructs
LD13IΔN contains Flag-tagged HOXD13 cloned into the EcoRI site of the LXIΔN
vector (Salsi and Zappavigna, 2006). Reporter constructs for the murine Hand2, Dach1,
Barx1, and Fbn1 HOXD13-bound regions were obtained by PCR from genomic DNA.
PCR-ampliﬁed fragments were sequenced and digested with KpnI/HindIII, KpnI/SacI,
KpnI/BamHI, and KpnI/BamHI for cloning, respectively. The Hand2, Barx1, and Dach1
fragments were cloned into the pT81-luc vector; the Fbn1 sequence was inserted into
the pXP2 promoter-less vector (Nordeen, 1988).
Cell culture, transfection, and retroviral transduction
SW1353 cells (ATCC# HTB-94) were cultured according to ATCC recommendations.
Viral stocks of LXIΔN and LD13IΔN were obtained as described in Salsi and Zappavigna
(2006). SW1353 cells were transduced as described previously (Salsi and Zappavigna,
2006). Puriﬁcation to near homogeneity of transduced cells was achieved by an
immunomagnetic procedure using mouse anti-human NGFR MoAb and secondary Ab-
coated beads (Dynabeads® Pan Mouse IgG 110-41 Invitrogen) following the
manufacturer guidelines. Expression of Flag-HOXD13 in SW1353 cells was veriﬁed by
immunoblotting using anti-Flag antibody (F3165, Sigma). P19 cells were cultured as
described in Salsi and Zappavigna (2006). Transfections were carried out by CaPO4
precipitation. Eight micrograms of reporter, 1.0–4.0 μg of expression construct, and
0.1 μg of CMV-βgal (Clontech), were used per 6 cm dish. After transfection, cells were
washed, lysed and assayed for luciferase and β-galactosidase as described in Salsi and
Zappavigna (2006).
Chromatin immunoprecipitation (ChIP) and amplicon generation
ChIP was performed as described previously (Salsi and Zappavigna, 2006). 2×106
FlagHOXD13-expressing SW1353 cells were immunoprecipitated with 5 μg of anti-Flag
antibody (F3165, Sigma) or anti-Myc control antibody (Santa Cruz sc-40, 9E10). ChIP-
on-chip amplicons were generated from two individual ChIPs and from input genomic
DNA by ligation-mediated PCR (LM-PCR) as described in Vigano et al. (2006).
Enrichment in the individual ChIPs was validated by semi-quantitative PCR on the
regulatory sequences of the HOXD13 targets EPHA7 (Salsi and Zappavigna, 2006) and
SHH (Capellini et al., 2006). For ChIP on embryonic limb chromatin, mouse fore- and
hind-limb buds, or distal (autopodal) regions, were dissected from ∼60 E11.5, or E13.5,
mouse embryos, respectively. Chromatin was incubated with 5 μg of anti-Hoxd13
(IMX-5106, Imgenex, San Diego), or with 5 μg of control anti-Flag (F3165, Sigma)
antibodies.
Chromatin amplicon labelling and microarray hybridisation
Chromatin amplicons were labelled as described in Vigano et al. (2006). Cy5-
labelled anti- Flag(HOXD13) and anti-Myc immunoprecipitated probes, together with
the Cy3-labelled input genomic DNAwere hybridised to a 12K CpG island microarray as
described in Vigano et al. (2006). Hybridised microarrays were scanned and analysed
using a ScanArray 4000 and QuantArray analysis software (Packard) as described in
Vigano et al. (2006). Only spots showing an enrichment of ≥2-fold in the anti-Flag(HOXD13) samples (direct comparison with anti-Flag(HOXD13) and anti-Myc IPs
hybridisations) were considered. Sequence information and location of the clones was
obtained from the UHN web site: http://data.microarrays.ca/cpg/index.htm. Gene
Ontology Consortium (GO) annotations (http://www.geneontology.org) were obtained
for each clone and clones were classiﬁed according to their function.
Semi-quantitative PCR and RT-PCR analysis
Semi-quantitative PCR analysis on ChIP samples was performed as described in
Salsi and Zappavigna (2006). Primers were designed using the Gene Fisher Primer
Calculation program (http://bibiserv.techfak.uni-bielefeld.de/geneﬁsher/) to obtain
similar annealing temperatures and fragment sizes of about 500 bp. Primers are listed
in Supplementary Table 2. PCR conditions were standardised for all primers andwere as
follows: 95 °C, 5 min, 1 cycle; 95 °C, 1 min, 63 °C, 1 min, 72 °C, 1 min for 34 cycles. Semi-
quantitative PCR analysis was performed on three independent ChIPs for each genomic
region analysed. For RT-PCR, RNA was extracted from SW1353 cells using the RNAeasy
kit (Qiagen) according to the manufacturer’s protocol. Three micrograms of total RNA
were used for cDNA synthesis. Expression levels were normalised to Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) amounts. Primers are listed in Supplementary
Table 2.
Avian retrovirus production, microinjection and whole-mount in situ hybridisation
RCAS-HOXD13 was described previously (Caronia et al., 2003). Production of
retroviral stocks of chick eggs and its microinjection were performed as described in
Caronia et al. (2003). Whole-mount in situ hybridisations using digoxigenin-labelled
antisense mRNA probes were performed as described in Wilkinson (1992).
Acknowledgments
We thank C. Tabin for the Shh and Dach1, Y. Kida for the Dach1, B.
Christ for the Bmp4, M.A. Ros for the Hand2, V. Marigo for the Bmp2, A.
Lumsden for the Emx2, J.C. Izpisua-Belmonte for the Meis2, M. Torres
for the Meis1, P. Bovolenta for the cSfrp1, and P. Francis-West for the
Barx1 chick in situ hybridisation probes. Thanks are also due to D.
Duboule for advice and discussion, to T. Heanue for tips on the use of
the chick Dach1 probe, to A. Grande for providing the LXIΔN retroviral
vector, and to C. Imbriano for the kind gift of the α-NF-YB antibody.
This workwas supported by grants (to VZ) from the Italian Association
for Cancer Research (AIRC), the Italian Association for the Study of
Malformations (ASM), and the Italian Ministry of University and
Research (MUR). This paper is dedicated to thememory of the late F.M.
Buy Zappavigna.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.02.048.
References
Abu-Shaar, M., Mann, R., 1998. Generation of multiple antagonistic domains along the
proximodistal axis during Drosophila leg development. Development 125,
3821–3830.
Arteaga-Solis, E., Gayraud, B., Lee, S.Y., Shum, L., Sakai, L., Ramirez, F., 2001. Regulation of
limb patterning by extracellular microﬁbrils. J. Cell Biol. 154, 275–281.
Bandyopadhyay, A., Tsuji, K., Cox, K., Harfe, B.D., Rosen, V., Tabin, C.J., 2006. Genetic
analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skele-
togenesis. PLoS Genet. 2, e216.
Barlow, A.J., Bogardi, J.P., Ladher, R., Francis-West, P.H., 1999. Expression of chick Barx-1
and its differential regulation by FGF-8 and BMP signaling in the maxillary pri-
mordia. Dev. Dyn. 214, 291–302.
Capdevila, J., Tsukui, T., Rodriquez Esteban, C., Zappavigna, V., Izpisua Belmonte, J.C.,
1999. Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal
antagonism of BMPs by Gremlin. Mol. Cell 4, 839–849.
Capellini, T.D., Di Giacomo, G., Salsi, V., Brendolan, A., Ferretti, E., Srivastava, D.,
Zappavigna, V., Selleri, L., 2006. Pbx1/Pbx2 requirement for distal limb patterning is
mediated by the hierarchical control of Hox gene spatial distribution and Shh
expression. Development 133, 2263–2273.
Caronia, G., Goodman, F.R., McKeown, C.M., Scambler, P.J., Zappavigna, V., 2003. An I47L
substitution in the HOXD13 homeodomain causes a novel human limb malforma-
tion by producing a selective loss of function. Development 130, 1701–1712.
Charite, J., McFadden, D.G., Olson, E.N., 2000. The bHLH transcription factor dHAND
controls Sonic hedgehog expression and establishment of the zone of polarizing
activity during limb development. Development 127, 2461–2470.
Cobb, J., Duboule, D., 2005. Comparative analysis of genes downstream of the Hoxd
cluster in developing digits and external genitalia. Development 132, 3055–3067.
507V. Salsi et al. / Developmental Biology 317 (2008) 497–507Cross, S.H., Charlton, J.A., Nan, X., Bird, A.P., 1994. Puriﬁcation of CpG islands using a
methylated DNA binding column. Nat. Genet. 6, 236–244.
Davis, A.P., Capecchi, M.R., 1996. A mutational analysis of the 5′ HoxD genes: dissection
of genetic interactions during limb development in the mouse. Development 122,
1175–1185.
Davis, R.J., Shen, W., Sandler, Y.I., Amoui, M., Purcell, P., Maas, R., Ou, C.N., Vogel, H.,
Beaudet, A.L., Mardon, G., 2001. Dach1 mutant mice bear no gross abnormalities in
eye, limb, and brain development and exhibit postnatal lethality. Mol. Cell. Biol. 21,
1484–1490.
Davis, R.J., Pesah, Y.I., Harding, M., Paylor, R., Mardon, G., 2006. Mouse Dach2 mutants
do not exhibit gross defects in eye development or brain function. Genesis 44,
84–92.
Davuluri, R.V., Grosse, I., Zhang, M.Q., 2001. Computational identiﬁcation of promoters
and ﬁrst exons in the human genome. Nat. Genet. 29, 412–417.
Deschamps, J., 2004. Developmental biology. Hox genes in the limb: a play in two acts.
Science 304, 1610–1611.
Dolle, P., Izpisua-Belmonte, J.C., Boncinelli, E., Duboule, D., 1991. The Hox-4.8 gene is
localized at the 5′ extremity of the Hox-4 complex and is expressed in the most
posterior parts of the body during development. Mech. Dev. 36, 3–13.
Dolle, P., Dierich, A., LeMeur, M., Schimmang, T., Schuhbaur, B., Chambon, P., Duboule, D.,
1993. Disruption of the Hoxd-13 gene induces localized heterochrony leading to
mice with neotenic limbs. Cell 75, 431–441.
Favier, B., Dolle, P., 1997. Developmental functions of mammalian Hox genes. Mol. Hum.
Reprod. 3, 115–131.
Favier, B., Rijli, F.M., Fromental-Ramain, C., Fraulob, V., Chambon, P., Dolle, P., 1996.
Functional cooperation between the non-paralogous genes Hoxa-10 and Hoxd-11
in the developing forelimb and axial skeleton. Development 122, 449–460.
Fernandez-Teran, M., Piedra, M.E., Kathiriya, I.S., Srivastava, D., Rodriguez-Rey, J.C.,
Ros, M.A., 2000. Role of dHAND in the anterior–posterior polarization of the
limb bud: implications for the Sonic hedgehog pathway. Development 127,
2133–2142.
Fromental-Ramain, C., Warot, X., Messadecq, N., LeMeur, M., Dolle, P., Chambon, P., 1996.
Hoxa-13 and Hoxd-13 play a crucial role in the patterning of the limb autopod.
Development 122, 2997–3011.
Geetha-Loganathan, P., Nimmagadda, S., Huang, R., Scaal, M., Christ, B., 2006. Expression
pattern of BMPs during chick limb development. Anat. Embryol. 211 (Suppl. 7),
87–93.
Goff, D.J., Tabin, C.J., 1997. Analysis of Hoxd-13 and Hoxd-11 misexpression in chick limb
buds reveals that Hox genes affect both bone condensation and growth.
Development 124, 627–636.
Goodman, F.R., 2002. Limb malformations and the human HOX genes. Am. J. Med.
Genet. 112, 256–265.
Guo, X., Day, T.F., Jiang, X., Garrett-Beal, L., Topol, L., Yang, Y., 2004. Wnt/beta-catenin
signaling is sufﬁcient and necessary for synovial joint formation. Genes Dev. 18,
2404–2417.
Hamburger, V., Hamilton, H.L., 1992. A series of normal stages in the development of the
chick embryo. 1951. Dev. Dyn. 195, 231–272.
Heanue, T.A., Davis, R.J., Rowitch, D.H., Kispert, A., McMahon, A.P., Mardon, G., Tabin, C.J.,
2002. Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the
developing eye and ear of both chick and mouse and is regulated independently of
Pax and Eya genes. Mech. Dev. 111, 75–87.
Heisler, L.E., Torti, D., Boutros, P.C., Watson, J., Chan, C., Winegarden, N., Takahashi, M.,
Yau, P., Huang, T.H., Farnham, P.J., Jurisica, I., Woodgett, J.R., Bremner, R., Penn, L.Z.,
Der, S.D., 2005. CpG Island microarray probe sequences derived from a physical
library are representative of CpG Islands annotated on the human genome. Nucleic
Acids Res. 33, 2952–2961.
Kawano, Y., Kypta, R., 2003. Secreted antagonists of the Wnt signalling pathway. J. Cell.
Sci. 116, 2627–2634.
Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., Haussler, D.,
2002. The human genome browser at UCSC. Genome Res. 12 (6), 996–1006.
Kida, Y., Maeda, Y., Shiraishi, T., Suzuki, T., Ogura, T., 2004. Chick Dach1 interacts with the
Smad complex and Sin3a to control AER formation and limb development along the
proximodistal axis. Development 131, 4179–4187.
Kim, B.M., Buchner, G., Miletich, I., Sharpe, P.T., Shivdasani, R.A., 2005. The stomach
mesenchymal transcription factor Barx1 speciﬁes gastric epithelial identity through
inhibition of transient Wnt signaling. Dev. Cell 8, 611–622.
Kmita, M., Tarchini, B., Zakany, J., Logan, M., Tabin, C.J., Duboule, D., 2005. Early
developmental arrest of mammalian limbs lacking HoxA/HoxD gene function.
Nature 435, 1113–1116.
Knezevic, V., De Santo, R., Schughart, K., Huffstadt, U., Chiang, C., Mahon, K.A., Mackem,
S., 1997. Hoxd-12 differentially affects preaxial and postaxial chondrogenic
branches in the limb and regulates Sonic hedgehog in a positive feedback loop.
Development 124, 4523–4536.
Knosp, W.M., Scott, V., Bachinger, H.P., Stadler, H.S., 2004. HOXA13 regulates the ex-
pression of bone morphogenetic proteins 2 and 7 to control distal limb mor-
phogenesis. Development 131, 4581–4592.
Kojima, T., Sato, M., Saigo, K., 2000. Formation and speciﬁcation of distal leg segments in
Drosophila by dual Bar homeobox genes, BarH1 and BarH2. Development 127,
769–778.
Lei, H., Wang, H., Juan, A.H., Ruddle, F.H., 2005. The identiﬁcation of Hoxc8 target genes.
Proc. Natl. Acad. Sci. U. S. A. 102, 2420–2424.
Mardon, G., Solomon, N.M., Rubin, G.M., 1994. dachshund encodes a nuclear protein
required for normal eye and leg development in Drosophila. Development 120,
3473–3486.
McFadden, D.G., McAnally, J., Richardson, J.A., Charite, J., Olson, E.N., 2002. Misexpres-sion of dHAND induces ectopic digits in the developing limb bud in the absence of
direct DNA binding. Development 129, 3077–3088.
Mercader, N., Leonardo, E., Azpiazu, N., Serrano, A., Morata, G., Martinez, C., Torres, M.,
1999. Conserved regulation of proximodistal limb axis development by Meis1/Hth.
Nature 402, 425–429.
Mercader, N., Leonardo, E., Piedra, M.E., Martinez, A.C., Ros, M.A., Torres, M., 2000.
Opposing RA and FGF signals control proximodistal vertebrate limb development
through regulation of Meis genes. Development 127, 3961–3970.
Morgan, B.A., Fekete, D.M., 1996. Manipulating gene expression with replication-
competent retroviruses. Methods Cell Biol. 51, 185–218.
Morgan, E.A., Nguyen, S.B., Scott, V., Stadler, H.S., 2003. Loss of Bmp7 and Fgf8 signaling
in Hoxa13-mutant mice causes hypospadia. Development 130, 3095–3109.
Nelson, C.E., Morgan, B.A., Burke, A.C., Laufer, E., DiMambro, E., Murtaugh, L.C., Gonzales,
E., Tessarollo, L., Parada, L.F., Tabin, C., 1996. Analysis of Hox gene expression in the
chick limb bud. Development 122, 1449–1466.
Nordeen, S.K., 1988. Luciferase reporter gene vectors for analysis of promoters and
enhancers. Biotechniques 6, 454–457.
Ouyang, P., 1998. An in vitro model to study mesenchymal–epithelial transformation.
Biochem. Biophys. Res. Commun. 246, 771–776.
Riddle, R.D., Johnson, R.L., Laufer, E., Tabin, C., 1993. Sonic hedgehog mediates the
polarizing activity of the ZPA. Cell 75, 1401–1416.
Rijli, F.M., Chambon, P., 1997. Genetic interactions of Hox genes in limb development:
learning from compound mutants. Curr. Opin. Genet. Dev. 7, 481–487.
Robinson, P.N., Arteaga-Solis, E., Baldock, C., Collod-Beroud, G., Booms, P., De Paepe, A.,
Dietz, H.C., Guo, G., Handford, P.A., Judge, D.P., Kielty, C.M., Loeys, B., Milewicz, D.M.,
Ney, A., Ramirez, F., Reinhardt, D.P., Tiedemann, K., Whiteman, P., Godfrey, M., 2006.
The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet.
43, 769–787.
Sakai, L.Y., Keene, D.R., Engvall, E., 1986. Fibrillin, a new 350-kD glycoprotein, is a
component of extracellular microﬁbrils. J. Cell Biol. 103, 2499–2509.
Salsi, V., Zappavigna, V., 2006. Hoxd13 and Hoxa13 directly control the expression of the
EphA7 ephrin tyrosine kinase receptor in developing limbs. J. Biol. Chem. 281,
1992–1999.
Satoh, W., Gotoh, T., Tsunematsu, Y., Aizawa, S., Shimono, A., 2006. Sfrp1 and Sfrp2
regulate anteroposterior axis elongation and somite segmentation during mouse
embryogenesis. Development 133, 989–999.
Schaefer, J.F., Millham, M.L., de Crombrugghe, B., Buckbinder, L., 2003. FGF signaling
antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma
cells. Osteoarthr. Cartil. 11, 233–241.
Spater, D., Hill, T.P., Gruber, M., Hartmann, C., 2006. Role of canonical Wnt-signalling in
joint formation. Eur. Cell Mater. 12, 71–80.
Srivastava, D., Thomas, T., Lin, Q., Kirby, M.L., Brown, D., Olson, E.N., 1997. Regulation of
cardiac mesodermal and neural crest development by the bHLH transcription
factor, dHAND. Nat. Genet. 16, 154–160.
Suzuki, M., Kuroiwa, A., 2002. Transition of Hox expression during limb cartilage
development. Mech. Dev. 118, 241–245.
Suzuki, M., Ueno, N., Kuroiwa, A., 2003. Hox proteins functionally cooperate with the GC
box-binding protein system through distinct domains. J. Biol. Chem. 278,
30148–30156.
Tarchini, B., Duboule, D., Kmita, M., 2006. Regulatory constraints in the evolution of the
tetrapod limb anterior–posterior polarity. Nature 443, 985–988.
Te Welscher, P., Zuniga, A., Fernandez-Teran, M., Ros, M., Kuijper, S., Drenth, T.,
Goedemans, H., Meijlink, F., Zeller, R., 2002. 1 Patterning the limb before and after
SHH. J. Anat. 201, 417.
Terry, K., Magan, H., Baranski, M., Burrus, L.W., 2000. Sfrp-1 and sfrp-2 are expressed in
overlapping and distinct domains during chick development. Mech. Dev. 97,
177–182.
Tickle, C., 2003. Patterning systems—from one end of the limb to the other. Dev. Cell 4,
449–458.
Valerius, M.T., Patterson, L.T., Witte, D.P., Potter, S.S., 2002. Microarray analysis of novel
cell lines representing two stages of metanephric mesenchyme differentiation.
Mech. Dev. 112, 219–232.
Vigano, M.A., Lamartine, J., Testoni, B., Merico, D., Alotto, D., Castagnoli, C., Robert, A.,
Candi, E., Melino, G., Gidrol, X., Mantovani, R., 2006. New p63 targets in
keratinocytes identiﬁed by a genome-wide approach. EMBO J. 25, 5105–5116.
Wilkinson, D.G., 1992. Whole Mount In Situ Hybridisation of Vertebrate Embryos.
Oxford Univ Press, Oxford, UK.
Williams, T.M., Williams, M.E., Kuick, R., Misek, D., McDonagh, K., Hanash, S., Innis, J.W.,
2005. Candidate downstream regulated genes of HOX group 13 transcription
factors with and without monomeric DNA binding capability. Dev. Biol. 279,
462–480.
Wu, K., Yang, Y., Wang, C., Davoli, M.A., D’Amico, M., Li, A., Cveklova, K., Kozmik, Z.,
Lisanti, M.P., Russell, R.G., Cvekl, A., Pestell, R.G., 2003. DACH1 inhibits transforming
growth factor-beta signaling through binding Smad4. J. Biol. Chem. 278,
51673–51684.
Wu, J., Smith, L.T., Plass, C., Huang, T.H., 2006. ChIP-chip comes of age for genome-wide
functional analysis. Cancer Res. 66, 6899–6902.
Zakany, J., Duboule, D., 1996. Synpolydactyly in mice with a targeted deﬁciency in the
HoxD complex. Nature 384, 69–71.
Zakany, J., Duboule, D., 1999. Hox genes in digit development and evolution. Cell Tissue
Res. 296, 19–25.
Zakany, J., Duboule, D., 2007. The role of Hox genes during vertebrate limb development.
Curr. Opin. Genet. Dev. 17, 359–366.
Zakany, J., Kmita, M., Duboule, D., 2004. A dual role for Hox genes in limb anterior–
posterior asymmetry. Science 304, 1669–1672.
